Nasso, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 2.049
AS - Asia 1.288
EU - Europa 1.048
SA - Sud America 199
Continente sconosciuto - Info sul continente non disponibili 46
AF - Africa 41
OC - Oceania 3
Totale 4.674
Nazione #
US - Stati Uniti d'America 1.984
SG - Singapore 363
CN - Cina 341
IT - Italia 298
IE - Irlanda 155
VN - Vietnam 149
GB - Regno Unito 135
BR - Brasile 134
HK - Hong Kong 122
BD - Bangladesh 114
DE - Germania 101
SE - Svezia 70
FR - Francia 60
RU - Federazione Russa 52
FI - Finlandia 46
KR - Corea 39
IN - India 37
ID - Indonesia 34
CA - Canada 33
AR - Argentina 28
PL - Polonia 19
MX - Messico 15
BE - Belgio 14
ZA - Sudafrica 14
CZ - Repubblica Ceca 13
NL - Olanda 13
UA - Ucraina 13
BG - Bulgaria 11
CO - Colombia 11
ES - Italia 11
LT - Lituania 10
CL - Cile 9
IQ - Iraq 9
TR - Turchia 9
AT - Austria 8
EC - Ecuador 8
JP - Giappone 8
MY - Malesia 8
CR - Costa Rica 6
KE - Kenya 6
SA - Arabia Saudita 6
TN - Tunisia 6
MA - Marocco 5
PH - Filippine 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
PK - Pakistan 4
SY - Repubblica araba siriana 4
AU - Australia 3
ET - Etiopia 3
EU - Europa 3
JM - Giamaica 3
JO - Giordania 3
RO - Romania 3
AZ - Azerbaigian 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HT - Haiti 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.632
Città #
Ashburn 286
Santa Clara 225
Singapore 199
Chandler 161
Dublin 153
San Jose 148
Hong Kong 120
Fairfield 105
Hefei 97
Dallas 89
Council Bluffs 73
Beijing 64
Nyköping 57
Ho Chi Minh City 56
London 53
Los Angeles 53
New York 42
Helsinki 39
Shanghai 38
Hanoi 37
Wilmington 37
Seoul 36
Houston 32
Ann Arbor 30
Modena 30
Munich 30
Seattle 29
Southend 29
Chicago 28
The Dalles 28
Jakarta 24
Cambridge 22
Lauterbourg 22
Milan 22
Moscow 20
Dearborn 17
Woodbridge 17
San Diego 15
Buffalo 14
São Paulo 14
Bremen 13
Columbus 13
Paris 13
Rome 13
Toronto 13
Bologna 12
Portsmouth 12
Princeton 12
Brooklyn 11
Des Moines 11
Fremont 11
Mumbai 11
Sofia 11
Warsaw 11
Falls Church 10
Guangzhou 10
Orem 10
Brno 9
Brussels 9
Charlotte 9
Florence 9
Parma 9
Boardman 8
Caprarola 8
Denver 8
Frankfurt am Main 8
Glasgow 8
Haiphong 8
Johannesburg 8
Montreal 7
Atlanta 6
Düsseldorf 6
Madrid 6
Nuremberg 6
Phoenix 6
Santorso 6
Tokyo 6
Changchun 5
Da Nang 5
Jacksonville 5
Kent 5
Mexico City 5
Reggio Emilia 5
San José 5
Savona 5
Tashkent 5
Baghdad 4
Bari 4
Biên Hòa 4
Carpi 4
Chennai 4
Curitiba 4
Dong Ket 4
Gdansk 4
Harbin 4
Hải Dương 4
Naples 4
Palermo 4
Porto Alegre 4
Quito 4
Totale 3.039
Nome #
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 367
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 360
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 354
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 317
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 294
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 282
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 266
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 264
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 263
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 240
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 234
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe 221
Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report 189
Chasing Circulating Biomarkers in Renal Cell Carcinoma: the Case of Extracellular Vesicles and their miRNA Cargos 174
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 167
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer (HR+/HER2- mBC): regulatory aspects and clinical impact in Europe 160
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications 154
Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma 145
Cerebellar metastasis of ovarian cancer: a case report 144
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients 79
Totale 4.674
Categoria #
all - tutte 18.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022313 0 62 18 6 16 18 17 30 33 13 54 46
2022/2023569 40 65 38 39 35 58 9 54 178 11 20 22
2023/2024297 18 17 26 38 32 33 26 25 17 18 15 32
2024/2025987 30 7 24 74 166 123 84 72 135 61 85 126
2025/20262.037 129 74 220 183 260 112 279 105 141 201 127 206
2026/2027122 43 79 0 0 0 0 0 0 0 0 0 0
Totale 4.674